370 related articles for article (PubMed ID: 36538077)
1. The star target in SLE: IL-17.
Yang Y; Yan C; Yu L; Zhang X; Shang J; Fan J; Zhang R; Ren J; Duan X
Inflamm Res; 2023 Feb; 72(2):313-328. PubMed ID: 36538077
[TBL] [Abstract][Full Text] [Related]
2. The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target.
Koga T; Ichinose K; Kawakami A; Tsokos GC
Expert Rev Clin Immunol; 2019 Jun; 15(6):629-637. PubMed ID: 30874446
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
[TBL] [Abstract][Full Text] [Related]
4. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
AlFadhli S; AlFailakawi A; Ghanem AA
Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
[TBL] [Abstract][Full Text] [Related]
7. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
8. Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
Selvaraja M; Abdullah M; Arip M; Chin VK; Shah A; Amin Nordin S
PLoS One; 2019; 14(11):e0224707. PubMed ID: 31697750
[TBL] [Abstract][Full Text] [Related]
9. Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus.
Koga T; Ichinose K; Kawakami A; Tsokos GC
Front Immunol; 2020; 11():624971. PubMed ID: 33597953
[TBL] [Abstract][Full Text] [Related]
10. Effects of Astragalus membranaceus on systemic lupus erythematosus in a mouse model of pregnancy.
Chen HQ; Zhang N; Li CX; Zhang HX
Immun Inflamm Dis; 2022 Jun; 10(6):e624. PubMed ID: 35634952
[TBL] [Abstract][Full Text] [Related]
11. RORγt expression in T
Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
[TBL] [Abstract][Full Text] [Related]
12. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
[TBL] [Abstract][Full Text] [Related]
13. T cells and IL-17 in lupus nephritis.
Koga T; Ichinose K; Tsokos GC
Clin Immunol; 2017 Dec; 185():95-99. PubMed ID: 27109641
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of IL-27 in systemic lupus erythematosus.
Pan HF; Tao JH; Ye DQ
Expert Opin Ther Targets; 2010 May; 14(5):479-84. PubMed ID: 20350048
[TBL] [Abstract][Full Text] [Related]
15. Is Th17-Targeted Therapy Effective in Systemic Lupus Erythematosus?
Petrić M; Radić M
Curr Issues Mol Biol; 2023 May; 45(5):4331-4343. PubMed ID: 37232744
[TBL] [Abstract][Full Text] [Related]
16. Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis.
Fakhfakh R; Zian Z; Elloumi N; Abida O; Bouallegui E; Houssaini H; Volpe E; Capone A; Hachicha H; Marzouk S; Bahloul Z; Masmoudi H
Immunol Res; 2022 Oct; 70(5):644-653. PubMed ID: 35666434
[TBL] [Abstract][Full Text] [Related]
17. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.
Shin MS; Lee N; Kang I
Curr Opin Rheumatol; 2011 Sep; 23(5):444-8. PubMed ID: 21720245
[TBL] [Abstract][Full Text] [Related]
18. Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus.
Chen SY; Liu MF; Kuo PY; Wang CR
Clin Rheumatol; 2019 May; 38(5):1361-1366. PubMed ID: 30767092
[TBL] [Abstract][Full Text] [Related]
19. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
Sippl N; Faustini F; Rönnelid J; Turcinov S; Chemin K; Gunnarsson I; Malmström V
Clin Exp Immunol; 2021 Jul; 205(1):44-52. PubMed ID: 33576004
[TBL] [Abstract][Full Text] [Related]
20. AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLK
Chuang HC; Chen YM; Chen MH; Hung WT; Yang HY; Tseng YH; Tan TH
FASEB J; 2019 Oct; 33(10):11469-11480. PubMed ID: 31318609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
